These stress pathways utilize specific eIF2␣ kinases to affect this goal. For example, PKR responds to the accumulation of double-stranded RNA during viral infection, GCN2 responds to uncharged tRNA in nutrientdeprived cells, and HRI matches the biosynthesis of 
. Activation of IRE1␣ was markedly increased in the pancreas noblot, the ratio of phosphorylated to total eIF2␣ in tissues of wild-type and PerkϪ/Ϫ mice. The ratio of phosof PerkϪ/Ϫ mice, consistent with higher levels of ER stress in that tissue ( Figure 1E ). phorylated to total eIF2␣ was significantly reduced in the pancreas, lung, and thymus of PerkϪ/Ϫ mice, To examine the phenotypic consequences of reduced eIF2␣ phosphorylation and the presumed defect in whereas in other tissues, such as the liver and spleen, there were no detectable differences between the ratio translational regulation in the pancreas of PerkϪ/Ϫ mice, we studied the control of blood glucose, which in wild-type and mutant animals ( Figure 1D ). These results indicate that PERK plays an important role in phosdepends on the ability of the endocrine portion of the pancreas to secrete insulin appropriately. Between birth phorylating eIF2␣, and may modulate translation in the pancreas and other tissues under physiological condiand 4 weeks of age, the PerkϪ/Ϫ mice experienced a marked deterioration in glycemic control. Before 2 tions. Other kinases such as GCN2 and PKR may account for residual levels of eIF2␣ phosphorylation in weeks of age, most PerkϪ/Ϫ animals had random blood glucose levels that were within the normal range for PerkϪ/Ϫ tissues.
If PERK is active under physiological conditions, one suckling mice. After 4 weeks of age, all of the PerkϪ/Ϫ animals had markedly elevated blood glucose levels might expect that the absence of PERK would result in ( Figure 2A ). The PerkϪ/Ϫ animals had significantly lower littermates in weight and longevity. Therefore, the defect in glycemic control observed in the Perkϩ/Ϫ animals body weights than wild-type littermates ( Figure 2B ), and serum insulin levels were reduced in the PerkϪ/Ϫ aniwas unlikely to have been secondary to other pleotrophic effects of the mutation and supports a primary mals ( Figure 2C ). These results indicate that the hyperglycemia in PerkϪ/Ϫ mice was due primarily to the failsite of action of the gene in the endocrine pancreas. To examine the anatomic basis for the defect in glyure of the endocrine pancreas to secrete adequate amounts of insulin and not as a consequence of periphcemic control of PerkϪ/Ϫ mice, we stained pancreatic sections with antisera to insulin and glucagon, the major eral resistance to the action of the hormone.
We also compared blood glucose levels in wild-type polypeptide hormones produced by the endocrine pancreas. At postnatal day 12, PerkϪ/Ϫ mice had normaland Perkϩ/Ϫ adult male mice following an intraperitoneal glucose injection. Wild-type mice cleared the gluappearing islets of Langerhans, with a thin mantle of glucagon-producing cells surrounding a large core of incose load more rapidly that the heterozygous mutant mice, indicating a mild defect in glycemic control in the sulin-producing cells. With time, however, the size of the islets decreased, the mass of insulin-producing cells Perkϩ/Ϫ mice ( Figure 2D ). This defect was observed in two isogenic strain backgrounds (129svev and F1 diminished, and the proportion of glucagon-positive cells increased, and they were found to populate the hybrids of 129svev and C57B/6), was stable over 26 weeks of observation, and did not lead to fasting hypercore of the islet as well as its mantle ( Figure 3A) . (Figure 3C) . These results suggest that increased cell death results indicate that PERK is not required for the suppression of insulin biosynthesis at low glucose levels. plays an important role in the progressive destruction of the insulin-producing cell mass in mutant mice.
The notable difference between wild-type and mutant islets was the higher level of insulin biosynthesis in the Insulin mRNA translation and protein biosynthesis as well as total protein biosynthesis are upregulated by mutant islets. This finding suggests that PERK activity attenuates the normal increase in insulin translation in is even lower in the reducing gel in which the ␣ chain, which contains 2/3 of the labeled residues, is not reislet cells responding to a carbohydrate load. Since serum insulin levels are tightly regulated at the level of tained ( Figure 4D ). The similar rates of conversion of proinsulin to insulin in the two genotypes indicated that hormone secretion, it is not surprising that the increased biosynthesis of insulin demonstrated here does not ER and post-ER processing of insulin was normal in PerkϪ/Ϫ mice, and argues against a general defect of translate into higher serum levels in the prediabetic mutant mice. We note that the PERK mutation preferentially ER function in the mutant islets. The exocrine portion of the pancreas contributes to affects insulin biosynthesis over total protein biosynthesis ( Figure 4A , lower panel). This is consistent with the more that 95% of its mass. PERK activation in wild-type mice and reduced eIF2␣ phosphorylation in pancreatic possibility of selective modulation of translation in membrane-bound ribosomes by PERK.
tissue extracts of mutant mice likely reflected events that took place in exocrine cells ( Figures 1B and 1D ). To address the role of the Perk mutation on the processing and maturation of newly synthesized insulin, we This suggested that under physiological conditions, the exocrine pancreas might have the potential for develperformed pulse-chase analysis of metabolically labeled wild-type and PerkϪ/Ϫ islets. To enhance the potential oping ER stress, which is mitigated by the activity of PERK. Therefore, we examined exocrine pancreatic effect of the Perk mutation, we increased the load on the ER by performing both the pulse labeling and the function in mutant mice. Exocrine pancreatic insufficiency results in inadequate secretion of digestive enchase in high (16.7 mM) glucose. As expected, insulin biosynthesis was greater in the PerkϪ/Ϫ islets. Howzymes and incomplete digestion of foodstuffs. One of the earliest and easiest to detect manifestations of panever, the rates of proinsulin clearance from the ER (revealed by immunoprecipitation with an antiserum to the creatic maldigestion is the presence of intact triglycerides in the stool, or so-called steatorrhea. Wild-type C peptide) and the rate of production of processed ␣ and ␤ chain dimers (immunoprecipitated with an antibody to mice are able to digest virtually all the fat in a 45% fat diet, and stool smears from wild-type mice stained with the mature hormone) were not measurably different in the two genotypes ( Figures 4C-4E Figures 6B-6D ). These cells PerkϪ/Ϫ mice experience rapid and progressive decline in endocrine and exocrine pancreatic function. The time generally had considerably fewer secretory granules than the normal counterparts in the same islet. We course to the development of florid hyperglycemia was invariably less than 4 weeks, and exocrine pancreatic screened through multiple sections of age-matched wild-type littermates and never observed a similar cell.
insufficiency, though more variable in onset, was observed in most mutant mice by 6-8 weeks of age. HistoIn many instances, it was clear that the dilated cisterna was continuous with the perinuclear cisterna, which was logical analysis and immunochemical marker studies show that both the endocrine and exocrine pancreases similarly filled with a dense content (Figures 6B and  6C ). These features indicate that the striking, dilated develop normally in PerkϪ/Ϫ mice and indicate that tissue dysfunction is acquired postnatally. structures represent abnormal ER cisterna. The abun- stress may also be relevant to the development of more We speculate that the islet cells in PerkϪ/Ϫ animals can common forms of human diabetes mellitus. The major compensate for the lack of translational control, and abnormality in most patients with the common, type II that these compensatory mechanisms allow the ER to form of the disease is peripheral resistance to the action maintain its function for some time. Indeed, pulse-chase of insulin. However, glucose intolerance develops only labeling experiments reveal that ER processing of proinafter ␤ cell decompensation renders the endocrine pansulin is normal in the bulk of PerkϪ/Ϫ ␤ cells, and that creas unable to keep up with the demand imposed by insulin secretion in response to glucose by mutant islets insulin resistance (Porte, 1999; Cavaghan et al.
, 2000). cultured in vitro is likewise preserved (Figures 4B and
We propose that over time, chronic ER stress might 4C, and data not shown). Eventually, the physiological contribute to the attrition of ␤ cell function and mass demands on the ␤ cell exhaust the capacity of these observed in many cases of type II diabetes mellitus. putative compensatory mechanisms. According to this According to this speculation, the mutation we created speculation, the occasional cells with massively dilated in Perk artificially accelerates a process that is played ER reflect the consequences of such decompensation. out over many years in the endocrine pancreas of paThe infrequency with which such cells are observed tients with type II diabetes mellitus. is possibly due to their dying soon after entering this presumably decompensated state. Increased activity of 63  62  61  60  59  58  57  56  55  54  53  52  51  50  49  48  47  46  45  44  43  42  41  40  39  38  37  36  35  34  33  32  31  30  29  28  27  26  25  24  23  22  21  20  19  18  17  16  15  14  13  12  11  10  9  8  7  6  5  4  3  2 Both groups show in genetically engineered mice that a protein kinase that phosphorylates a master regulator of translation-eukaryotic translation initiation factor-2 (eIF2)-promotes the survival of insulin-secreting pancreatic β cells, thus contributing to glucose homeostasis.
Genetic and biochemical analyses of the yeast Saccharomyces cerevisiae (3) has shown that a single known kinase, Gcn2p, that phosphorylates the α subunit of eIF2, leading to inhibition of protein synthesis. Gcn2p itself is activated by uncharged transfer RNAs (tRNAs without attached amino acids) under starvation conditions when the amino acid pool is depleted. Paradoxically, synthesis of the transcription factor Gcn4p is enhanced in response to activation of Gcn2p and phosphorylation of eIF2α (3). Gcn4p switches on expression of genes encoding enzymes that make amino acids. Thus, in yeast, phosphorylation of eIF2α serves predominantly to regulate gene expression at the transcriptional level in response to nutritional deprivation.
In eukaryotes, translational control operates primarily during the first steps of translation when the small (40S) ribosomal subunit, charged with an initiator tRNA, is recruited to the 5′ end of mRNA. Initiation of translation is modulated in part by the activity of the eIF4F complex that recognizes the modified 5′ end of mRNA, and in part by eIF2, which recruits the charged initiator tRNA to the 40S ribosomal subunit. Phosphorylation of a serine at position 51 (Ser 51 ) in the α subunit of eIF2 is crucial for preventing this step and for halting protein synthesis. When phosphorylated, eIF2 inhibits the guanine nucleotide exchange factor eIF2B, becoming trapped in its inactive (guanosine diphosphate-bound) form and unable to initiate translation (3).
Four distinct kinases are known to phosphorylate eIF2α on Ser 51 in mammals. Each is activated by specific signals that elicit translational control in response to distinct needs. RNA-activated protein kinase is activated by double-stranded RNA produced during viral infection and halts protein synthesis, thus preventing production of viral proteins. Heme-regulated inhibitor kinase is activated when heme concentrations in maturing red blood cells become too low, switching off synthesis of globin. Perturbed protein folding in the endoplasmic reticulum (ER) induces eIF2α phosphorylation and the attenuation of protein synthesis (see the figure) (4). The kinase responsible for this unfolded protein response is PERK (5) . Identified as the eIF2 kinase enriched in pancreatic cells (6) , PERK is a transmembrane protein resident in the ER membrane whose activity is repressed by the ER chaperone BiP. When too many unfolded proteins accumulate in the ER, BiP dissociates from PERK, resulting in the activation of this kinase, which then phosphorylates eIF2α (7, 8) . Through halting translation initiation and protein synthesis, PERK may relieve ER stress by reducing the number of unfolded proteins in the ER (9, 10) .
By engineering PERK-deficient mice (1) or mice with a mutation in the eIF2α phosphorylation site (Ser 51 → Ala) (2), Harding, Scheuner, and their colleagues reveal that eIF2α phosphorylation is connected to glucose metabolism. The PERK-deficient and Ser 51 mutant mice exhibited severe but opposing defects in glucose homeostasis. PERK-deficient animals developed marked hyperglycemia (elevated blood glucose) at 4 weeks of age, whereas the Ser 51 mutant mice were normal at birth but died of severe hypoglycemia 18 hours later. Both mutant strains had defects in pancreatic β cells; these defects were apparent in Ser 51 mutant embryos, but only became apparent in PERK-def icient animals several weeks after birth.
The difference between the two animal models suggests that more than one type of eIF2 kinase may be operating in the insulin-producing β cells of the pancreas. A feature common to both mouse models is the decrease (but not complete absence) of β cells, large numbers of which undergo apoptosis in the PERK-deficient mice (11) . That the loss of β cells appears in the setting of hyperglycemia in one model and hypoglycemia in the other implies that this β cell insufficiency is directly caused by loss of normal eIF2α-mediated translational control and is not a secondary effect in response to disruption of glucose homeostasis.
The fatal hypoglycemia in the Ser 51 mutant mice may be caused by defects in glucose production in the liver (gluconeogenesis). In utero, the fetus is supplied with ample amounts of glucose through the placental circulation. At birth, this source of glucose is extinguished and the newborn mammal must activate enzymes that promote the conversion of gluconeogenesis precursors to glucose. The induction of this gluconeogenesis program is defective in the eIF2α mutant mice, as reflected by their failure to increase the amount of the gluconeogenic enzyme phosphoenol-pyruvate carboxykinase (PEPCK). Intriguingly, synthesis of one of the transcription factors that induces expression of the PEPCK gene is regulated by eIF2α phosphorylation. It will thus be important to determine whether loss of eIF2α phosphorylation decreases synthesis of this transcription factor in the liver cells of mutant mice. Phosphorylation of eIF2α is clearly
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Why is it that mice with defective eIF2α phosphorylation exhibit both β cell insufficiency and defective liver gluconeogenesis, whereas PERK-deficient animals only exhibit β cell insuff iciency? The Harding et al. work (1) provides a possible answer: PERK-deficient mice have a reduced ratio of phosphorylated to total eIF2α in pancreas, lung, and thymus, but a normal ratio in liver and spleen. This finding suggests that an eIF2α kinase other than PERK may be the key modulator of translational control of gluconeogenic enzyme expression in the liver. If eIF2α phosphorylation does prove to be important in this pathway, the mammalian homolog of yeast GCN2 (which is activated by amino acid deprivation) may be involved (see the figure) . Defective gene expression downstream of GCN2, however, is unlikely to account for all of the characteristics of the eIF2 mutant mice, given that GCN2-deficient animals do not manifest any impairment in neonatal survival (12) .
The importance of the new mouse models is underscored by the discovery of mutations in the PERK gene in an inherited autosomal recessive disease in humans, called the Wolcott-Rallison syndrome (13) . This disease is classified as a form of type 1 diabetes because it develops in early infancy and is characterized by the destruction of pancreatic β cells. A key question posed by the Harding and Scheuner studies is why β cells are selectively destroyed in Wolcott-Rallison patients and in the mutant mice. It is very likely that β cells die because they need both PERK (which is extraordinarily abundant in the pancreas) and eIF2α phosphorylation to survive.
In yeast, eIF2α is phosphorylated in response to nutritional cues and directs adaptations in intermediary metabolism. The new work suggests that, despite considerable diversification in upstream signals, metazoans have retained the kinases that phosphorylate eIF2α and control translation, adapting them for the regulation of glucose homeostasis.
